Gelesis
Latest round
- Series A
Last raised
- May 2011
Total raised
- $22M
Investors
- 3
About Gelesis
Founded in 2006 and based in Massachusetts, US, Gelesis Inc. is a biotechnology company that develops therapeutics for the treatment of obesity and chronic diseases. CEO Mr. Yishai Zohar and CTO Mr. In July 2021, Gelesis Inc., a SPAC (special purpose acquisition company), at an enterprise value of approximately USD 1 million. The company's development team manufactures and provides Plenity, biomimetic superabsorbent hydrogels made from cellulose and citric acid used to manage weight for adults suffering from excess weight and metabolic disorders.'s biotherapeutic formulation help patients feel full and eat less. The company also develops potential therapies to treat GI-related chronic diseases such as Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH), and Functional Constipation. Gelesis Inc. plans to list on the New York stock exchange under the ticker symbol GLS upon completing the merger agreement.
Who invested in Gelesis
3 investors across 3 rounds
See all investors in Gelesis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gelesis
Who invested in Gelesis?
Gelesis has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gelesis raised?
Gelesis has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Gelesis last raise money?
Gelesis's most recent round on record is a Series A, in May 2011.
What does Gelesis do?
Founded in 2006 and based in Massachusetts, US, Gelesis Inc.
Where is Gelesis headquartered?
Gelesis is headquartered in Boston, US.
Which VCs invest in companies like Gelesis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Gelesis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Gelesis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.